Upcoming FDA-AACR Workshop Will Discuss Dosage Optimization for Cancer Therapies
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...
Tag: AACR workshops
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Cancer is very complex, and the tools that we need to understand how it develops and progresses come from...